Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: a novel diagnostic method

Aims The purpose of this study was to establish contrast-enhanced ultrasound perfusion imaging (CUPI) of the lower extremities as a novel non-invasive diagnostic tool for patients with peripheral arterial disease (PAD). Methods and results Ultrasound contrast agent (SonoVue™) was injected into a per...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 27; no. 3; pp. 310 - 315
Main Authors Duerschmied, Daniel, Olson, Lisa, Olschewski, Manfred, Rossknecht, Alexandra, Freund, Gabriele, Bode, Christoph, Hehrlein, Christoph
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.02.2006
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims The purpose of this study was to establish contrast-enhanced ultrasound perfusion imaging (CUPI) of the lower extremities as a novel non-invasive diagnostic tool for patients with peripheral arterial disease (PAD). Methods and results Ultrasound contrast agent (SonoVue™) was injected into a peripheral vein of 16 control subjects and 16 PAD patients and its appearance in the calf muscle was detected by low-energy harmonic ultrasound. Analysis of the wash-in curves revealed that PAD patients had a significantly longer time to peak intensity (TTP), i.e. duration of maximum contrast perfusion [37 s (19–79 s) in control subjects vs. 56 s (32–104 s) in PAD patients at rest, age-adjusted P=0.002]. Exercise stress test of the calf muscle resulted in a decrease of the TTP, maintaining the significant difference in TTP between the groups [19 s (8–37 s) in control subjects vs. 32 s (18–48 s) in PAD patients after exercise, age-adjusted P=0.004]. Neither ankle-brachial index and TTP nor age and TTP showed a significant correlation. Conclusion CUPI reflects the regional blood circulation of the calf muscle. In this pilot study, PAD patients show a significantly longer TTP than control subjects. The clinical relevance of CUPI is topic of ongoing studies.
Bibliography:ark:/67375/HXZ-FXB9KRJG-2
local:ehi636
href:ehi636
Corresponding author. Tel: +49 761 270 3401; fax: +49 761 270 3699. E-mail address: duerschmied@medizin.ukl.uni-freiburg.de
istex:134494084732CDC9DDF7C9B05BC22092CD663DA6
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehi636